This is a preview of subscription content, log in via an institution to check access.
Notes
2019 US dollars
Reference
Berkley HH, et al. Mifepristone Combination Therapy Compared With Misoprostol Monotherapy for the Management of Miscarriage: A Cost-Effectiveness Analysis. Obstetrics and Gynecology : 10 Sep 2020. Available from: URL: http://doi.org/10.1097/AOG.0000000000004063
Rights and permissions
About this article
Cite this article
Mifepristone plus misoprostol less costly than misoprostol alone. PharmacoEcon Outcomes News 863, 20 (2020). https://doi.org/10.1007/s40274-020-7174-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-7174-x